A real-life ImmunoCAT study: impact of molecular diagnosis through ImmunoCAPTM ISAC 112 on immunotherapy prescription in pollen-polysensitized patients in Catalonia, Spain.
Garriga-Baraut T, Labrador-Horrillo M, Tena M, Linares C, Esteso-Hontoria O, Pedemonte C, Basagaña-Torrento M, Miquel S, Padró-Casas C, Campa-Falcon N, Ferré-Ybarz L, Gázquez-Garcia V, Muñoz-Cano R, Viñas M, Farrarons L, Baltasar-Dragó M, Cortés N, Asensio O, Bartra J, Belmonte J, Bobolea I, Raga E, Moncín MSM.
Garriga-Baraut T, et al. Among authors: basagana torrento m.
Allergol Immunopathol (Madr). 2024 Jul 1;52(4):21-29. doi: 10.15586/aei.v52i4.1077. eCollection 2024.
Allergol Immunopathol (Madr). 2024.
PMID: 38970261